Get ready for the next wave of pharmaceutical and medical device litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
Download a publication order form here or subscribe here.
Drugs & Medical Devices - Issue: 23
CMO Bank - Baycol/Meridia/PPA/Prempro/Propulsid - November 2003
CMO Bank - Rezulin/Serzone - November 2003
Ephedra Litigation and Chapter 11: A HarrisMartin Interview with Paul Rheingold, Esq.
FDA Should Propose Rule on Federal Preemption of Failure-to-Warn Lawsuits
Journal Watch - Columns-Drugs & Supplements - November 2003
The Warnings Page
Appellate Court Affirms Rejection of Metabolife's Attempt to Invoke Anti-SLAPP Statute
Judge Rules Damages for Celebrex-Related Injury Under the Jurisdictional Limit
